
Henry Schein (HSIC) Stock Forecast & Price Target
Henry Schein (HSIC) Analyst Ratings
Bulls say
Henry Schein is a well-established company with a strong reputation in the dental market and potential for growth in the medical market. It is focused on reducing costs and expanding margins and has a respected leadership team with a clear growth plan. Despite some concerns about declining dental coverage and security risks, HSIC is expected to continue growing and is a solid choice for investors.
Bears say
Henry Schein is a well-known and dominant player in the healthcare distribution industry, serving a diversified and global customer base. However, the company's 2026 and 2027 projected increase in EBITDA seems relatively small compared to its cost reduction initiatives and the potential for price increases. Additionally, the company's heavy reliance on its Global Distribution and Value-Added Services segment and the potential threats of tariffs and changing healthcare policies may pose risks to its growth. With a relatively low valuation compared to its peers, Henry Schein's stock may be volatile and may not attract potential investors.
This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.
Henry Schein (HSIC) Analyst Forecast & Price Prediction
Start investing in Henry Schein (HSIC)
Order type
Buy in
Order amount
Est. shares
0 shares